Stock Watch: Why Pharma Should Care About UnitedHealth’s Woes
Litigation Is Probably Not The Best Answer To The Inflation Reduction Act
Hospital procedures are rebounding following the pandemic and the US population is aging. But what sounds like good news for pharma is curbed by the risk of Medicare insolvency, and suing the government cannot solve that.
